The Valley Desk

NCT03349710 · Interventional trial

Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer

Overall registry status Completed

Phase 3

Conditions Squamous Cell Carcinoma of the Head and Neck

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov